The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 04, 2022

Filed:

Jul. 31, 2018
Applicant:

The Trustees of Columbia University IN the City of New York, New York, NY (US);

Inventors:

Donald W. Landry, New York, NY (US);

Shi-Xian Deng, White Plains, NY (US);

Xiaoming Xu, Fair Lawn, NJ (US);

Thomas Diacovo, Larchmont, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 239/90 (2006.01); A61P 35/00 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/52 (2006.01); A61K 31/573 (2006.01); C07D 401/12 (2006.01); C07D 403/14 (2006.01); C07D 473/16 (2006.01);
U.S. Cl.
CPC ...
C07D 239/90 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/52 (2013.01); A61K 31/573 (2013.01); A61P 35/00 (2018.01); C07D 401/12 (2013.01); C07D 403/14 (2013.01); C07D 473/16 (2013.01);
Abstract

In an aspect, the disclosure provides for compounds (II), compositions, and methods of administering the compounds and compositions to a patient in need thereof. In another aspect, the disclosure relates to compounds and compositions for treating cancer, for example, lymphoid leukemia. The disclosure further provides for compounds which inhibit two phosphoinositide 3-kinase (PI3K) isoforms, y and δ, pharmaceutical compositions comprising said compounds, and methods of using said compounds and pharmaceutical compositions for treatment, amelioration, and/or prevention of non-Hodgkin lymphoma.


Find Patent Forward Citations

Landry, Donald. (2022). Compounds, compositions, and methods for treating t-cell acute lymphoblastic leukemia (U.S. Patent No. 11459306). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11459306

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…